A
Axsome Therapeutics D
D
AXSM
105.335
USD
1.42
(1.36%)
مغلق
حجم التداول
8,537
الربح لكل سهم
-4
العائد الربحي
-
P/E
-18
حجم السوق
5,186,312,507
الأخبار المقالات
العنوان: Axsome Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.